2.2. Treatment methods
hypoglycemic
DISEASE, COMPLICATIONS, CEREBROVASCULAR DISEASES
Standard basic treatment measures with reference to the China Guidelines for the Prevention and Treatment of Cerebrovascular Diseases developed by the Department of Disease Control of the Ministry of Health and the Neurological Society of the Chinese Medical Association in 2005 were adopted for both trial and control groups. Individualized treatment was used to control and stabilize blood pressure to ≤135/85 mm Hg or within the normal range. Appropriate hypoglycemic drugs were selected to control and maintain normal blood glucose levels. Similarly, appropriate lipid-lowering drugs were chosen based on triglyceride and cholesterol levels. Symptomatic treatment, prevention and treatment of complications were assessed.